Compare IGD & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IGD | TCMD |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.0M | 533.5M |
| IPO Year | N/A | 2016 |
| Metric | IGD | TCMD |
|---|---|---|
| Price | $6.05 | $30.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | ★ 305.5K | 185.3K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 9.15% | N/A |
| EPS Growth | N/A | ★ 17.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.58 | $9.42 |
| 52 Week High | $6.41 | $37.77 |
| Indicator | IGD | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 74.10 |
| Support Level | $5.65 | $29.11 |
| Resistance Level | $6.15 | $30.74 |
| Average True Range (ATR) | 0.09 | 1.06 |
| MACD | -0.02 | 0.30 |
| Stochastic Oscillator | 8.09 | 95.78 |
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.